For research use only. Not for therapeutic Use.
Anti-MRC2 / CD280 is a monoclonal antibody targeting ENDO180. It can be used as therapeutic strategy of sarcoma subtypes, primary tumor and in metastatic disease. MW :142.92 KD.
| Catalog Number | I047135 |
| Purity | ≥95% |
| Reference | [1] Evans RJ, et al. Mol Cancer Ther. 2023 Feb 1;22(2):240-253 |
